Cure My Disease

Don't miss your cure!

 Log in / Sign up

Healing hands: touch therapy may soothe ICU agitation and pain

NCT ID NCT07061340

Symptom relief Sponsor: Firat University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether therapeutic touch—a gentle, non-invasive therapy—can help reduce agitation, pain, and stress hormone levels in intensive care patients. About 60 adults who are awake and stable in the ICU will either receive this touch therapy or standard care. The goal is to see if this simple, drug-free approach can improve comfort and recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years and above. * Patients who can communicate verbally. * Patients who have been monitored in the intensive care unit for at least 4 days. * Patients who are able to give informed consent. * Patients who are hemodynamically stable. * Richmond Agitation-Sedation Scale 1 and above. * Visual Analog Scale 1 and above. Exclusion Criteria: 1. Patients under deep sedation. 2. Patients on mechanical ventilation. 3. Patients with psychiatric problems. 4. Patients with skin diseases or open wounds, infections, burns that would prevent therapeutic touch. 5. Patients using sedative/analgesic drugs (excessive sedation or delirium). 6. Patients using corticosteroids or drugs that affect adrenal hormone levels (because these drugs can affect cortisol measurements). 7. Patients who have sudden life-threatening clinical changes during intensive care (e.g. sudden cardiac arrest, shock).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Therapeutic touch are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain Psychomotor Agitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Therapeutic touch

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fırat university

    Elâzığ, Center, 25240, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.